Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Because Retatrutide is still undergoing Phase 3 research, there is no confirmed launch date
In STEP 1, in a population of obese or overweight people without diabetes, those who received semaglutide 2.4 mg plus a lifestyle intervention over 68 weeks lost an average of 14.9% in bodyweight as compared with just a 2.4% reduction in the placebo plus lifestyle intervention group
The regions large and diverse population presents a significant opportunity for market expansion, especially as awareness of innovative weight loss therapies continues to rise
2014;37:e76e77
Most patients experience some reduction in appetite and improvement in blood sugar control within the first 1-2 weeks
US$ 28.70
US$ 25.58
US$ 27.21
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 28.92
US$ 21.14
US$ 21.86
